TMEM144 inhibitors are a category of chemical compounds specifically designed to target the transmembrane protein 144 (TMEM144), which is a member of the larger family of transmembrane proteins. These inhibitors work by interfering with the normal function of TMEM144, which is typically involved in various cellular processes that include signaling pathways and cellular homeostasis. The inhibition is usually achieved by binding to the protein at specific sites, which can alter its conformation, mask critical regions necessary for its activity, or interfere with its ability to interact with other cellular components. The precise molecular mechanisms by which TMEM144 contributes to cellular functions are complex and involve a series of intricate biochemical interactions, making the development of these inhibitors a challenge that requires a nuanced understanding of protein structure and function.
The creation of TMEM144 inhibitors is a sophisticated process that involves several stages, including the identification of the protein's active or binding sites and the subsequent design of molecules that can effectively target these sites. This can involve a range of techniques, from high-resolution imaging of the protein's structure, like X-ray crystallography or cryo-electron microscopy, to computational models that simulate the docking of potential inhibitors with the protein. Once potential inhibitory compounds are identified, they undergo various modifications to improve their specificity and affinity for TMEM144, as well as to optimize other properties such as solubility and stability. The chemical structures of TMEM144 inhibitors are diverse, potentially including small peptides, peptidomimetics, or organic molecules that possess the necessary characteristics to interact with the transmembrane protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that prevents degradation of ubiquitinated proteins. If TMEM144 is involved in ubiquitination processes or affected by them, MG132 can modulate its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can affect cellular processes such as survival and growth. Depending on TMEM144's specific role, LY294002 can modulate its activity. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
PI3K inhibitor affecting autophagy. If TMEM144 plays a role in or is modulated by autophagy, 3-MA can influence its function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that impedes the MAPK pathway. If TMEM144 is involved in or modulated by the MAPK pathway, PD98059 can modulate its activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor. If TMEM144 has any interaction or modulation via the JNK pathway, SP600125 can influence its activity. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Protein synthesis inhibitor. By affecting protein synthesis, cycloheximide might indirectly affect the expression levels of TMEM144. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor. If TMEM144 has any interaction or modulation via the p38 pathway, this compound can influence its activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that affects various cellular processes. Depending on TMEM144's involvement in these processes, wortmannin can modulate its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor influencing autophagy and other cellular processes. If TMEM144 is associated with the mTOR pathway or autophagy, rapamycin can impact its function. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Specific inhibitor of vacuolar-type H+-ATPase that affects autophagy. If TMEM144's role intersects with autophagy, bafilomycin A1 can modulate its activity. | ||||||